Skip to content
R

Ralf Duerr

Publications (4)

Pharmacovigilance of Natural Herbal Medicines Research for Efficacy, Safety and Quality Assurance of Phytomedicine Products

Estella Tembe Fokunang, Dobgima John Fonmboh, Rose Ngono Mballa, Andrew Banin Nyuyki, Lovet Benyella Fokunang, Nubia Kaba, Thérèse Bwemba Abong, Ralf Duerr, Ejoh Richard, Marie-Thérèse Abena Ondoua & Charles Ntungwen Fokunang · Journal of Complementary and Alternative Medical Research · 2020

Improved traditional medicine/phytomedicine formulations have gained a global acceptability and popularity as therapeutic agents for many diseases in Sub-Saharan Africa. Herbal products are generally considered as safe, environmentally friendly and increasingly consumed by the co...

Open access Research Article 10.9734/jocamr/2020/v12i130198

An Overview of Pharmacovigilance and Adverse Drug Reaction Monitoring of Drugs and Vaccines during the COVID-19 Pandemic

Estella Achick Tembe-Fokunang, Banin Andrew Nyuki, Joseph Fokam, Dobgima John Fonmboh, Kristen Nubia Kaba, Lovet Benyella Fokunang, François-Xavier Mbopi-Keou, Abena, Ondoua Obama Marie Therese, Ralf Duerr & Charles Ntungwen Fokunang · Journal of Advances in Medical and Pharmaceutical Sciences · 2022

Once a drug is approved in phase III of clinical trials, pharmacovigilance (PV) becomes very important for the surveillance of drug, vaccine or medical devices. PV constitutes part of the phase IV approval, which involves a study for collecting, detecting, and monitoring adverse...

Open access Research Article 10.9734/jamps/2022/v24i630308

Pharmacovigilance in Cameroon: Past, Present and Future Developments in Unlocking the Drug Development Process

Estella Achick Tembe Fokunang, Bruna Njeba, Marie Jose Essi, Rose Ngono Abondo, Banin Andrew Nyuki, Lovet Benyella Fokunang, Nubia Kaba, Marie-Thérèse Abena Ondoua, Ralf Duerr & Charles Ntungwen Fokunang · Journal of Advances in Medical and Pharmaceutical Sciences · 2020

The drug discovery and development processes are designed to guarantee that drugs are efficacious, nontoxic and of high standards of quality for human consumption. However, patient’s population with access to drugs at approval is only a fraction of the final target population. Th...

Open access Research Article 10.9734/jamps/2020/v22i930192

An Overview of COVID-19 Vaccines: Challenges of the Discovery and Development by the Pharmaceutical Industries

Estella Achick Tembe-Fokunang, Andrew Nyuyki Banin, Joseph Fokam, Dobgima John Fonmboh, Kristen Nubia Kaba, Lovet Benyella Fokunang, Ben Enoluomen Ehigiator, Zelinjo N. Igweze, Sarah Tishkoff, Ralf Duerr & Charles Ntungwen Fokunang · International Journal of Pathogen Research · 2022

The coronavirus (COVID-19) took the world by storm and triggered intensive research mobilization and action towards vaccines and drug repurposing. This pandemic triggered an emergence therapy intervention of which the development of new vaccine and drug repurposing were good opti...

Open access Research Article 10.9734/ijpr/2022/v11i2209